DD237185A5 - Verfahren zur herstellung von festuclavin - Google Patents
Verfahren zur herstellung von festuclavin Download PDFInfo
- Publication number
- DD237185A5 DD237185A5 DD85276813A DD27681385A DD237185A5 DD 237185 A5 DD237185 A5 DD 237185A5 DD 85276813 A DD85276813 A DD 85276813A DD 27681385 A DD27681385 A DD 27681385A DD 237185 A5 DD237185 A5 DD 237185A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- festuclavin
- fermentation
- production
- medium
- culture
- Prior art date
Links
- VLMZMRDOMOGGFA-PSOPSSQASA-N Pyroclavine Natural products C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-PSOPSSQASA-N 0.000 title claims abstract description 13
- VLMZMRDOMOGGFA-WDBKCZKBSA-N festuclavine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-WDBKCZKBSA-N 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title claims abstract 4
- 238000000855 fermentation Methods 0.000 claims abstract description 9
- 230000004151 fermentation Effects 0.000 claims abstract description 9
- 241000124224 Claviceps paspali Species 0.000 claims abstract description 4
- 244000005700 microbiome Species 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 229960003133 ergot alkaloid Drugs 0.000 claims description 2
- VLMZMRDOMOGGFA-RIEGTJTDSA-N costaclavin Chemical compound C1=CC([C@@H]2C[C@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-RIEGTJTDSA-N 0.000 claims 1
- 238000009413 insulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 239000002609 medium Substances 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 229960001230 asparagine Drugs 0.000 description 4
- 235000009582 asparagine Nutrition 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- NHJPVZLSLOHJDM-UHFFFAOYSA-N azane;butanedioic acid Chemical compound [NH4+].[NH4+].[O-]C(=O)CCC([O-])=O NHJPVZLSLOHJDM-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- -1 zinc cations Chemical class 0.000 description 2
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 2
- ZHJGWYRLJUCMRT-UHFFFAOYSA-N 5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide Chemical compound C=1C=CC=C(C(F)(F)F)C=1C(C)OC(=C(S1)C(N)=O)C=C1N(C1=C2)C=NC1=CC=C2CN1CCN(C)CC1 ZHJGWYRLJUCMRT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001268782 Paspalum dilatatum Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- OQEZHYDMAVYVEQ-UHFFFAOYSA-N lithium nitrate tetrahydrate Chemical compound [Li+].O.O.O.O.[O-][N+]([O-])=O OQEZHYDMAVYVEQ-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
- C12P17/183—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing an indolo[4,3-F,G]quinoleine nucleus, e.g. compound containing the lysergic acid nucleus as well as the dimeric ergot nucleus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843420955 DE3420955A1 (de) | 1984-06-01 | 1984-06-01 | Verfahren zur herstellung von festuclavin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD237185A5 true DD237185A5 (de) | 1986-07-02 |
Family
ID=6237691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD85276813A DD237185A5 (de) | 1984-06-01 | 1985-05-30 | Verfahren zur herstellung von festuclavin |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4939089A (cs) |
| EP (1) | EP0189430B1 (cs) |
| JP (1) | JPS61502375A (cs) |
| CS (1) | CS271314B2 (cs) |
| DD (1) | DD237185A5 (cs) |
| DE (2) | DE3420955A1 (cs) |
| HU (1) | HU198099B (cs) |
| WO (1) | WO1985005634A1 (cs) |
-
1984
- 1984-06-01 DE DE19843420955 patent/DE3420955A1/de not_active Withdrawn
-
1985
- 1985-05-30 DD DD85276813A patent/DD237185A5/de not_active IP Right Cessation
- 1985-05-30 EP EP85902478A patent/EP0189430B1/de not_active Expired - Lifetime
- 1985-05-30 HU HU852883A patent/HU198099B/hu not_active IP Right Cessation
- 1985-05-30 WO PCT/DE1985/000189 patent/WO1985005634A1/de active IP Right Grant
- 1985-05-30 JP JP60502498A patent/JPS61502375A/ja active Pending
- 1985-05-30 DE DE8585902478T patent/DE3575165D1/de not_active Expired - Lifetime
- 1985-05-30 US US06/842,110 patent/US4939089A/en not_active Expired - Fee Related
- 1985-05-31 CS CS853921A patent/CS271314B2/cs not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT38397A (en) | 1986-05-28 |
| JPS61502375A (ja) | 1986-10-23 |
| HU198099B (en) | 1989-07-28 |
| DE3420955A1 (de) | 1985-12-05 |
| CS271314B2 (en) | 1990-09-12 |
| DE3575165D1 (de) | 1990-02-08 |
| EP0189430A1 (de) | 1986-08-06 |
| WO1985005634A1 (en) | 1985-12-19 |
| US4939089A (en) | 1990-07-03 |
| CS392185A2 (en) | 1990-02-12 |
| EP0189430B1 (de) | 1990-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3051175C2 (cs) | ||
| DE69720379T2 (de) | Verfahren zur Herstellung von Erythritol | |
| DE68920973T2 (de) | Antibiotika und deren Verfahren zur Herstellung. | |
| DE2417337B2 (de) | Verfahren zur biotechnischen Herstellung von L-Lysin | |
| DE2707105A1 (de) | Verfahren zur herstellung von l-arginin auf mikrobiologischem wege | |
| EP0189430B1 (de) | Verfahren zur herstellung von festuclavin | |
| EP0185691B1 (de) | Verfahren zur herstellung von chanoclavin | |
| DE3123001C2 (cs) | ||
| DE2028403B2 (de) | Pepstatin | |
| EP0183739B1 (de) | VERFAHREN ZUR HERSTELLUNG VON $g(a)-ERGOKRYPTIN | |
| DE1155413B (de) | Verfahren zur biotechnischen Herstellung von Gibberellinsaeure | |
| DE3783141T2 (de) | Verfahren zur herstellung von ketotraubensaeure mittels gaerung. | |
| DE2358496C2 (de) | Herstellung von L-Serin | |
| DE2413961C2 (de) | Biotechnische Herstellung von Citronensäure | |
| DE2849666A1 (de) | Verfahren zur herstellung des antibiotikums c-15003 p 4 | |
| DE69001554T2 (de) | Polyzyklische Verbindungen und deren Herstellung. | |
| DE3881566T2 (de) | Antitumor-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| DE2316429A1 (de) | Verfahren zur herstellung eines neuen metaboliten | |
| DE2517762A1 (de) | Verfahren zur herstellung von mit l-lysin angereicherten hefen, die selbst bei der gaerung citronen-, isocitronen- und glutaminsaeure produzieren | |
| DE975919C (de) | Verfahren zur Gewinnung eines Mutterkornalkaloidgemisches | |
| DD156189A5 (de) | Verfahren zur herstellung von mutterkornalkaloiden,insbesondere ergokornin und beta-ergokryptin | |
| DE69016851T2 (de) | Verfahren zur Herstellung von S-2,2-R1,R2-1,3-Dioxolan-4-methanol. | |
| DE3031334C2 (de) | Mikrobiologisches Verfahren zur Herstellung von Cholansäurederivaten | |
| DE2438031A1 (de) | Verfahren zur biotechnischen herstellung von l-lysin | |
| CH523317A (de) | Verfahren zur Herstellung eines neuen Antibioticums |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VZ | Disclaimer of patent (art. 11 and 12 extension act) |